| POKRIVČÁK, Tomáš, Jiří NAVRÁTIL, Alexandr POPRACH, Michal STANÍK a Igor KISS. Long-Term Efficacy and Safety of Enzalutamide Monotherapy in Elderly Patients with Metastatic Castration-Resistant Prostate Cancer: A Case Report. CASE REPORTS IN ONCOLOGY. BASEL: KARGER, 2024, roč. 17, č. 1, s. 537-542. ISSN 1662-6575. Dostupné z: https://dx.doi.org/10.1159/000538124. |
Další formáty:
BibTeX
LaTeX
RIS
@article{2407957,
author = {Pokrivčák, Tomáš and Navrátil, Jiří and Poprach, Alexandr and Staník, Michal and Kiss, Igor},
article_location = {BASEL},
article_number = {1},
doi = {http://dx.doi.org/10.1159/000538124},
keywords = {Enzalutamide; Metastatic castration-resistant prostate cancer; Aged 75 and over; Comorbidity},
language = {eng},
issn = {1662-6575},
journal = {CASE REPORTS IN ONCOLOGY},
title = {Long-Term Efficacy and Safety of Enzalutamide Monotherapy in Elderly Patients with Metastatic Castration-Resistant Prostate Cancer: A Case Report},
url = {https://karger.com/cro/article/17/1/537/898017/Long-Term-Efficacy-and-Safety-of-Enzalutamide},
volume = {17},
year = {2024}
}
TY - JOUR
ID - 2407957
AU - Pokrivčák, Tomáš - Navrátil, Jiří - Poprach, Alexandr - Staník, Michal - Kiss, Igor
PY - 2024
TI - Long-Term Efficacy and Safety of Enzalutamide Monotherapy in Elderly Patients with Metastatic Castration-Resistant Prostate Cancer: A Case Report
JF - CASE REPORTS IN ONCOLOGY
VL - 17
IS - 1
SP - 537-542
EP - 537-542
PB - KARGER
SN - 16626575
KW - Enzalutamide
KW - Metastatic castration-resistant prostate cancer
KW - Aged 75 and over
KW - Comorbidity
UR - https://karger.com/cro/article/17/1/537/898017/Long-Term-Efficacy-and-Safety-of-Enzalutamide
N2 - Introduction: Prostate cancer is one of the most common cancers in men. Despite the sharp rise in incidence, mortality is decreasing. ARTA preparations are preferred options for asymptomatic or mildly symptomatic patients with mCRPC. The use of enzalutamide in elderly patients with mCRPC is risky and depends on a number of factors. An increased risk of falls and fractures has been shown. Case Presentation: We present a case report of an elderly patient with mCRPC treated with enzalutamide with very good long-term tolerance and efficacy. Conclusion: Despite the older age, no reduction of therapy was necessary in the patient due to good tolerance. Administration of enzalutamide in full doses resulted in a very good effect of therapy.
ER -
POKRIVČÁK, Tomáš, Jiří NAVRÁTIL, Alexandr POPRACH, Michal STANÍK a Igor KISS. Long-Term Efficacy and Safety of Enzalutamide Monotherapy in Elderly Patients with Metastatic Castration-Resistant Prostate Cancer: A Case Report. \textit{CASE REPORTS IN ONCOLOGY}. BASEL: KARGER, 2024, roč.~17, č.~1, s.~537-542. ISSN~1662-6575. Dostupné z: https://dx.doi.org/10.1159/000538124.
|
